ATE245436T1 - Cyclosüporin formulierung - Google Patents

Cyclosüporin formulierung

Info

Publication number
ATE245436T1
ATE245436T1 AT97901147T AT97901147T ATE245436T1 AT E245436 T1 ATE245436 T1 AT E245436T1 AT 97901147 T AT97901147 T AT 97901147T AT 97901147 T AT97901147 T AT 97901147T AT E245436 T1 ATE245436 T1 AT E245436T1
Authority
AT
Austria
Prior art keywords
pct
weight
compositions
dimethyl
sec
Prior art date
Application number
AT97901147T
Other languages
English (en)
Inventor
Milan Stuchlik
Tomas Andrysek
Alexander Jegorov
Ales Husek
Vladimir Matha
Josef Stuchlik
Original Assignee
Ivax Cr A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Cr A S filed Critical Ivax Cr A S
Application granted granted Critical
Publication of ATE245436T1 publication Critical patent/ATE245436T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97901147T 1996-01-18 1997-01-17 Cyclosüporin formulierung ATE245436T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ1996169A CZ288631B6 (cs) 1996-01-18 1996-01-18 Léčivé přípravky s obsahem cyklosporinu
PCT/GB1997/000131 WO1997026003A1 (en) 1996-01-18 1997-01-17 Cyclosporin formulation

Publications (1)

Publication Number Publication Date
ATE245436T1 true ATE245436T1 (de) 2003-08-15

Family

ID=5461334

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901147T ATE245436T1 (de) 1996-01-18 1997-01-17 Cyclosüporin formulierung

Country Status (12)

Country Link
US (1) US6046163A (de)
EP (1) EP0874640B1 (de)
JP (1) JP4005134B2 (de)
KR (1) KR100471680B1 (de)
AT (1) ATE245436T1 (de)
AU (1) AU1449497A (de)
CZ (1) CZ288631B6 (de)
DE (1) DE69723671T2 (de)
DK (1) DK0874640T3 (de)
ES (1) ES2207714T3 (de)
PT (1) PT874640E (de)
WO (1) WO1997026003A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CZ267796A3 (cs) 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
KR100587551B1 (ko) 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
US6136985A (en) * 1997-12-23 2000-10-24 Dcv, Inc. CLA esters and uses thereof
PT1058711E (pt) * 1998-03-04 2003-08-29 Ato Bv Derivados de biciclo octano utilizados como um plastificante
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ES2216517T3 (es) 1998-05-29 2004-10-16 Skyepharma Canada Inc. Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
EP1105096B1 (de) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injizierbare wässerige propofoldispersionen
IL143197A0 (en) 1998-11-20 2002-04-21 Rtp Pharma Inc Dispersible phospholipid stabilized microparticles
WO2000040219A1 (en) 1998-12-30 2000-07-13 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
DE60020382T2 (de) * 1999-09-21 2006-01-26 Skyepharma Canada Inc., Verdun Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AUPQ877300A0 (en) * 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
PT1435910E (pt) * 2001-10-19 2009-09-07 Isotechnika Inc Novos pré-concentrados de microemulsão de análogos da ciclosporina
EP1549299B1 (de) * 2002-06-05 2014-08-20 IVAX Pharmaceuticals s.r.o. Verringerung der gelatine-vernetzung
ES2295541T5 (es) * 2003-01-08 2012-06-27 Swiss Caps Rechte Und Lizenzen Ag Cuerpos moldeados constituidos por material exento de gelatina y rellenos con una masa de carga líquida
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
FR2971941B1 (fr) * 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
EP0327280B1 (de) * 1988-01-29 1992-03-18 Sankyo Company Limited Cyclosporin-Zusammensetzungen
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
EP0451461B1 (de) * 1990-02-23 1994-04-27 BASF Aktiengesellschaft Verwendung von Mischungen aus Polyglycerinfettsäureestern als Emulgatoren in kosmetischen und pharmazeutischen Zubereitungen
CZ278863B6 (en) * 1992-09-07 1994-07-13 Galena Medicinal preparations with n-methylated cyclic undecapeptides
CN1077800C (zh) * 1993-07-01 2002-01-16 韩美药品工业株式会社 环孢菌素软胶囊组合物
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
EP0690697A1 (de) * 1993-12-24 1996-01-10 Koninklijke Philips Electronics N.V. Bilderzeugung mittels magnetischer resonanz vom grase (gradient- und spin-echo)-typ mit korrektur der auslesegradienten-polarität und t2-messung
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물

Also Published As

Publication number Publication date
DE69723671D1 (de) 2003-08-28
CZ288631B6 (cs) 2001-08-15
US6046163A (en) 2000-04-04
DK0874640T3 (da) 2003-11-17
DE69723671T2 (de) 2004-04-22
JP2000503314A (ja) 2000-03-21
WO1997026003A1 (en) 1997-07-24
PT874640E (pt) 2003-12-31
KR19990077360A (ko) 1999-10-25
JP4005134B2 (ja) 2007-11-07
ES2207714T3 (es) 2004-06-01
CZ16996A3 (en) 1997-08-13
KR100471680B1 (ko) 2007-04-25
AU1449497A (en) 1997-08-11
EP0874640B1 (de) 2003-07-23
EP0874640A1 (de) 1998-11-04

Similar Documents

Publication Publication Date Title
ATE245436T1 (de) Cyclosüporin formulierung
ES2153385T3 (es) Composicion acuosa a base de hormona del crecimiento humana.
ES2183865T3 (es) Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.
CY2233B1 (en) Compositions to treat onychomycoses
PT786986E (pt) Formulacoes farmaceuticas
AR030933A1 (es) Derivados del triazol y composiciones farmaceuticas que los contienen
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
IL139960A0 (en) Macrocylic analogs and methods of their use and preparation
GB0031312D0 (en) Macrolides
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
PL311637A1 (en) Poured over preparations containing a polymer as well as glycerides and glycols
ES2131515T3 (es) Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
ES2058228T3 (es) Compuestos activos sobre el sistema cardiovascular.
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
DE50204884D1 (de) Kosmetische formulierung enthaltend dihydroxyaceton
ES2078378T3 (es) Composiciones que tienen actividad herbicida conteniendo n-alquil-amidas como ingrediente activo.
DE69207777D1 (de) Körperpflegemittel
AU1085392A (en) Alkyl ether carboxylic acid taurides
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
ES2006521A6 (es) Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion
ES2074985T3 (es) Derivados de benzopiran (4,3-d)-tiazol con actividad anti-alergica, anti-anafilactica y anti-artritica y composiciones que lo contienen.
KR970702691A (ko) 유기조직의 보존을 위한 디알킬 (c₁-c6)-케톤 퍼옥시드 조성물, 그리고 보존시의 조성물의 사용 및 동물 또는 인간 유기 조직들의 해부 준비(compositions containing dialkyl(c₁-c6)-ketone peroxide for the preservation of organic tissues, and application of said compositions to the preservation and anatomical preparation of organic tissues of animal or human origin)
MX9705592A (es) Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0874640

Country of ref document: EP

REN Ceased due to non-payment of the annual fee